secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senseonics Holdings, Inc. (SENS)
CIK:        0001616543
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001104659-24-074005
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senseonics sees H1 2024 net rev $10M, +21% YoY; FY 2024 guidance $22-24M
------------------------------------------------------------------------

- Reaffirmed H1 2024 global net revenue $10M, 21% growth over H1 2023.
- US new patient starts H1 2024 >200% higher than H1 2023.
- FDA 510(k) for 365-day Eversense on track for Q4 2024 launch.
- Mercy Health collaboration initiated; first insertions targeted Q3 2024.
- FY 2024 revenue guidance $22-24M; cash utilization ~$70M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1616543/000110465924074005/0001104659-24-074005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1616543/000110465924074005/tm2417819d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-074005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer